Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05868239 · ClinicalTrials.gov registry record · NA
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
A NA study of COVID-19 and Cardiac Arrest, sponsored by KidSIM Simulation Program.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 4
- Study locations
NCT05868239: Recruiting NA study of COVID-19 and Cardiac Arrest, sponsored by KidSIM Simulation Program.
NCT05868239 is a NA study of COVID-19 and Cardiac Arrest that is actively recruiting participants, run by KidSIM Simulation Program. The registered enrollment target is 240 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05868239, a NA study of COVID-19 and Cardiac Arrest, is actively recruiting participants, sponsored by KidSIM Simulation Program.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 4
- Study locations
Study Summary
Aerosol Generating Medical Procedures (AGMP) are procedures that have the potential to create tiny particles suspended in the air. These particles can contain germs such as viruses. The Coronavirus Disease 2019 (COVID-19) pandemic was caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients infected with SARS-CoV-2 experience unusually high rates of critical illness that needs advanced airway management and intensive care unit admission. Bag-valve-mask (BVM) ventilation, endotracheal Intubation (ETI) and chest compressions are sometimes required for critically ill COVID-19 patients, and may contribute to a high risk of infection amongst Health Care Workers (HCW). To lessen HCW risk during high-risk procedures, a device called an aerosol box has been developed to place over the head of the patient, shielding the provider's face from virus droplets suspended in the air. The purpose of this research study is to better understand how particles disperse during AGMPs, more specifically during the provision of cardiopulmonary resuscitation (CPR). The project team hopes what is learned from the project can help inform infection control measures. This could help make changes to the clinical environment and make it safer for HCW's. The investigators intend to explore how an aerosol box performs in reducing contamination of HCW's who perform critical airway interventions during resuscitation events.
Primary Outcome
A continuous measure defined as percentage of chest compressions (CC) meeting American Heart Association guidelines for CC depth and rate at the same time during resuscitation
Conditions Studied
Interventions
- DEVICE Aerosol box
Study Locations (4)
California
- Department of Emergency Medicine, Children's Hospital of Los Angeles - Los Angeles
Alberta
- KidSIM, Alberta Children's Hospital - Calgary
Ontario
- Department of Pediatrics, The Hospital for Sick Children - Toronto
Quebec
- Department of Pediatrics, CHU Sainte-Justine - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT05868239 shows while recruiting
NCT05868239 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Aerosol box is the first listed.
NCT05868239 reports a single indexed study location in California, Alberta, Ontario.
Frequently Asked Questions
What is clinical trial NCT05868239 about?
NCT05868239 is a clinical study titled "Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study". Aerosol Generating Medical Procedures (AGMP) are procedures that have the potential to create tiny particles suspended in the air. These particles can contain germs such as viruses. The Coronavirus Disease 2019 (COVID-19) pandemic was caused by the novel severe acute respiratory syndrome coronavirus...
What is the current status of trial NCT05868239?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-09-01. Estimated completion is 2026-12-01.
What conditions does trial NCT05868239 study?
This clinical trial studies the following conditions: COVID-19, Cardiac Arrest, Coronavirus.
What interventions are being tested in trial NCT05868239?
The interventions under investigation include: Aerosol box (DEVICE).
Who is sponsoring clinical trial NCT05868239?
This trial is sponsored by KidSIM Simulation Program, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05868239 being conducted?
This trial has 4 study locations across California, Alberta, Ontario, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05868239's enrollment target sits among peer trials
240 151st of 298 higher than 147 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
-
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI